Neurological improvement and rehabilitation potential following toxic myelopathy due to intrathecal injection of doxorubicin

Spinal Cord

Volumn 42, Issue 6, 2004, Pages 371-373

  Jordan, B ^a   Pasquier, Y ^a   Schnider, A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Doxorubicin; Intrathecal; Recovery; Rehabilitation; Toxic myelopathy

Indexed keywords

DOXORUBICIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; LABORATORY TEST; LYMPHOBLASTOMA; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; SPINAL CORD DISEASE; TREATMENT OUTCOME;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; ELECTROMYOGRAPHY; FEMALE; HUMANS; INJECTIONS, SPINAL; LYMPHOMA, LYMPHOBLASTIC; MUSCLE, SKELETAL; RECOVERY OF FUNCTION; SPINAL CORD DISEASES; TREATMENT OUTCOME;

EID: 3042739076     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3101592     Document Type: Article

References (18)

1. Slyter H, Liwnicz B, Herrick MK, Mason R. Fatal myeloencephalopathy caused by intrathecal vincristine. Neurology 1980; 30: 867-871.
2. Williams ME, Walker AN, Bracikowski JP, Garner L, Wilson KD, Carpenter JT. Ascending myeloencephalopathy due to intratechal vincristine sulfate. A fatal chemotherapeutic error. Cancer 1983; 51: 2041-2047.
3. Manelis J, Freudlich E, Ezekiel E, Doron J. Accidental intratechal vincristine administration. Report of a case. J Neurol 1982; 228: 209-213.
4. Resar LM, Phillips PC, Kastan MB, Leventhal BG, Bowman PW, Civin CI. Actue neurotoxicity after intratechal cytosine arabinoside in two adolescents with acute lymphobastic leukemia of B-cell type. Cancer 1993; 71: 117-123.
5. Mena H, Garcia JH, Velandia F. Central and peripheral myelinopathy associated with systemic neoplasia and chemotherapy. Cancer 1981; 48: 1724-1737.
6. Kwack EK, Kim DJ, Park TI, Cho KR, Kkwon IH, Sohn YK. Neural toxicity induced by accidental intrathecal vincristine administration. J Korean Med Sci 1999; 14: 668-692.
7. Arico M, Nespoli L, Porta F, Caselli D, Raiteri E, Burgio GR. Severe acute encephalopathy following inadvertent intrathecal doxorubicin administration. Med Pediatr Oncol 1990; 18: 261-263.
8. Meggs WJ, Hoffman RS. Fatality resulting from intraventricular vincristine administration. J Toxicol Clin Toxicol 1998; 36: 243-246.
9. Al Fawaz IM. Fatal myeloencephalopathy due to intratechal vincristine administration. Ann Trop Paediatr 1992; 12: 339-342.
10. Zaragoza MR, Ritchey ML, Walter A. Neurourologic consequences of accidental intratechal vincristine: a case report. Med Pediatr Oncol 1995; 24: 61-62.
11. Kleinschmidt-DeMasters BK, Yeh M. 'Locked-In-Syndrome' after intratechal cytosine arabinoside therapy for malignant immunoblastic lymphoma. Cancer 1992; 70: 2504-2507.
12. Garcia-Tena J et al. Intratechal chemotherapy-related myeloencephalopathy in a young child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1995; 12: 377-385.
13. Ribeiro C, Reis FC. Adhesive lumbar arachnoiditis. Acta Med Port 1998; 11: 59-65.
14. Gaidys WG, Dickerman JD, Walters CL, Young PC. Intratechal vincristine. Report of a fatal case despite CNS washout. Cancer 1983; 52: 789-801.
15. Lafolie P, Liliemark J, Bjork O, Aman J, Wranne L, Peterson C. Exchange of cerebrospinal fluid in accidental intrathecal overdose of cytarabine. Med Toxicol Adverse Drug Exp 1998; 3: 248-252.
16. Al Feraysan A, Russell NA, Al Wohaibi M, Awada A, Scherman B. Cerebrospinal fluid lavage in the treatment of inadvertent intrathecal vincristine injection. Childs Nerv Syst 1999; 15: 87-89.
17. Grush OC, Morgan SK. Folinic acid rescue for vincristine toxicity. Clin Toxicol 1979; 14: 71-78.
18. Michelagnoli MP, Bailey CC, Wilson I, Livingston J, Kinsey SE. Potential salvage therapy for inadvertent intratechal administration of vincristine. Br J Haematol 1997; 99: 364-367.